Arlinda Lee
Stock Analyst at Canaccord Genuity
(1.36)
# 3,526
Out of 5,067 analysts
41
Total ratings
36.59%
Success rate
-0.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arlinda Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Maintains: Buy | $18 → $21 | $9.23 | +127.52% | 3 | Sep 7, 2023 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $600 → $300 | $3.80 | +7,794.74% | 3 | Apr 5, 2022 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $375 → $90 | $58.64 | +53.48% | 5 | Mar 16, 2022 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $45 → $36 | $106.58 | -66.22% | 3 | Mar 7, 2022 | |
| CELC Celcuity | Initiates: Buy | $50 | $101.15 | -50.57% | 1 | Oct 8, 2021 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $151 → $160 | $51.25 | +212.20% | 3 | Aug 16, 2021 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $36 → $40 | $6.74 | +493.47% | 3 | Jul 15, 2021 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $92 → $105 | $32.78 | +220.32% | 12 | Oct 29, 2020 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $23 → $27 | $74.00 | -63.51% | 3 | May 19, 2020 | |
| BDTX Black Diamond Therapeutics | Initiates: Buy | $50 | $3.85 | +1,198.70% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $5.56 | +4,756.12% | 3 | Nov 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $160 | $0.44 | +36,090.91% | 1 | Mar 29, 2018 |
Delcath Systems
Sep 7, 2023
Maintains: Buy
Price Target: $18 → $21
Current: $9.23
Upside: +127.52%
X4 Pharmaceuticals
Apr 5, 2022
Maintains: Buy
Price Target: $600 → $300
Current: $3.80
Upside: +7,794.74%
Nektar Therapeutics
Mar 16, 2022
Maintains: Buy
Price Target: $375 → $90
Current: $58.64
Upside: +53.48%
Rhythm Pharmaceuticals
Mar 7, 2022
Maintains: Buy
Price Target: $45 → $36
Current: $106.58
Upside: -66.22%
Celcuity
Oct 8, 2021
Initiates: Buy
Price Target: $50
Current: $101.15
Upside: -50.57%
CRISPR Therapeutics AG
Aug 16, 2021
Maintains: Buy
Price Target: $151 → $160
Current: $51.25
Upside: +212.20%
Bicycle Therapeutics
Jul 15, 2021
Maintains: Buy
Price Target: $36 → $40
Current: $6.74
Upside: +493.47%
Ultragenyx Pharmaceutical
Oct 29, 2020
Maintains: Buy
Price Target: $92 → $105
Current: $32.78
Upside: +220.32%
Halozyme Therapeutics
May 19, 2020
Maintains: Buy
Price Target: $23 → $27
Current: $74.00
Upside: -63.51%
Black Diamond Therapeutics
Feb 24, 2020
Initiates: Buy
Price Target: $50
Current: $3.85
Upside: +1,198.70%
Nov 5, 2019
Maintains: Buy
Price Target: $225 → $270
Current: $5.56
Upside: +4,756.12%
Mar 29, 2018
Maintains: Buy
Price Target: $300 → $160
Current: $0.44
Upside: +36,090.91%